Bath & Body Works (NYSE:BBWI) shares gained 2.6% in pre-market trading on Tuesday after Citi upgraded the specialty retailer to Buy from Neutral, arguing that the stock’s steep decline following its previous earnings update has created a more attractive risk-reward profile.
Citi assigned the shares a fair value of $31.24, implying substantial upside from current levels. The upgrade also shifts the analyst picture more positively, with Bath & Body Works now carrying four Buy recommendations alongside coverage that remains predominantly rated Hold.
Upgrade Arrives Ahead of Q2 Earnings
The timing of Citi’s upgrade is particularly significant as Bath & Body Works prepares to publish its second-quarter 2026 results before the market opens on Wednesday.
Investors have been repositioning ahead of the announcement, which could provide an important near-term catalyst for a stock that has experienced considerable volatility over the past year.
The company has also recently declared a quarterly cash dividend of $0.20 per share. The shares are scheduled to trade ex-dividend on August 21, adding another event for income-focused investors to monitor this week.
Bath & Body Works Outperforms a Weaker Market
The advance in Bath & Body Works shares came despite a broadly negative backdrop for U.S. equities.
The S&P 500 fell 0.5% in pre-market trading, while the Nasdaq declined 1.3% and the Dow slipped 0.1%. The contrast suggests the move in Bath & Body Works was primarily driven by company-specific factors rather than broader market strength.
The stock remains well below its 52-week high of $32.32 following sustained pressure over the past year. Against that backdrop, Citi’s $31.24 valuation implies considerable recovery potential if the retailer can deliver an improvement in operating performance.
Depressed Valuation Draws Investor Attention
Bath & Body Works shares have previously traded as low as $14.28 over the past 52 weeks, leaving the company’s valuation significantly below its recent peak.
That decline has increasingly attracted attention from investors assessing whether expectations have become overly pessimistic and whether the market has already incorporated much of the company’s operational challenges into the share price.
Citi’s upgrade provides additional support for that argument, although Wednesday’s earnings report will offer investors a fresh opportunity to assess the retailer’s sales trends, profitability and outlook.
Earnings and Dividend Put BBWI in Focus
The combination of the analyst upgrade, imminent quarterly results and approaching ex-dividend date helped Bath & Body Works (NYSE:BBWI) outperform a declining broader market in pre-market trading.
With the shares still significantly below their 52-week high, attention is now turning to whether the upcoming earnings release can provide evidence that the company’s challenges are stabilising and support the recovery potential suggested by Citi’s new Buy recommendation.
Bath & Body Works stock price
